Five more states have joined the Federal Trade Commission's lawsuit accusing telehealth company Hims & Hers of sharing customers' sensitive health information with advertising platforms including Meta and Snap, the FTC said Tuesday. The expansion puts seven states behind the federal case and signals to any company handling health-related data that sending it to ad platforms draws coordinated federal and state scrutiny.

What Happened

The FTC filed an amended complaint in the U.S. District Court for the Northern District of California adding Arizona, Florida, Nebraska, Ohio and Wisconsin as co-plaintiffs. Utah and California, acting through Los Angeles County Counsel, joined the agency when it first sued in July. The commission voted 2-0 to authorize the new filing.

The claims rest on the FTC Act, the Restore Online Shoppers' Confidence Act, a federal law against deceptive online subscription billing, and the consumer protection laws of all seven states. According to the FTC's case page, the amended complaint asks for a permanent injunction, a declaratory judgment, a monetary judgment and civil penalties. It names no dollar amounts.

RelatedU.S. Moves to Seize $1.2 Billion From Binance Theft and Disrupts North Korean Fake-Meeting Scheme

The core privacy allegation is that Hims shared sensitive information about customers' medical conditions with Meta, Snap and other third parties while telling consumers its services kept their information private. In its July announcement, the FTC said the company did so by sending lists of certain customers to the platforms and by using third-party tracking technology that automatically reported what visitors did on its website.

The complaint also alleges that Hims charged consumers for prescriptions almost immediately after they submitted an online intake form, without clearly saying so, even as it told them they could first consult a medical provider. The FTC further alleges the company made subscriptions hard to cancel, including by placing the online cancellation option behind several steps.

These are allegations. The FTC files a complaint when it has reason to believe the law is being violated, and the court will decide the case. When the original suit was filed in July, Hims said in a statement that the FTC "contorts the law to try to manufacture claims," NPR reported, and called the case an effort to generate headlines at the company's expense. The FTC's announcement Tuesday did not include a response from the company.

Why It Matters

For boards and executives at health, telehealth and wellness companies, the case shows how routine marketing tools can become legal liabilities. Advertising pixels and similar trackers, small pieces of code that report visitor activity back to ad platforms, can carry health details when placed on intake forms or condition-specific pages. Regulators are treating that as a broken privacy promise, not a technical oversight.

State participation raises the stakes. Each added state brings its own consumer protection law and enforcement office, and the complaint seeks civil penalties alongside federal remedies. The billing and cancellation claims also reach beyond health care, putting any subscription business on notice that sign-up and cancellation flows face the same scrutiny as data practices.

Companies should know which trackers run on pages where customers enter medical or other sensitive information, what data those tools send, and whether privacy statements match that reality.

What to Watch

Key signals include Hims' formal answer to the amended complaint, any motion to dismiss and how the court rules on it, and whether additional states join. The scope of any eventual injunction will indicate what limits regulators expect on sharing health-related data with advertisers.